company

BIOMEDISINSK HELSE AS

1185 OSLO

Return on Equity
−17,78 %
Current Ratio
15,28
Debt-to-Equity Ratio
0,25
Key figures (NOK)2022
Revenue318 000
Net Income−146 000
Total Assets1 091 000
Total Equity821 000
Income (NOK)2022
Revenue318 000
Expenditure509 000
Operating Profit−191 000
Financial Income5 000
Financial Costs0
Financial Balance5 000
Earnings Before Tax−187 000
Tax−41 000
Net Income−146 000
Balance (NOK)2022
Total Fixed Assets52 000
Total Current Assets1 039 000
Total Assets1 091 000
Total Retained Equity721 000
Total Equity821 000
Total Long-Term Debt202 000
Total Current Debt68 000
Total Equity and Debt1 091 000
Cash flow (NOK)2022
Sales Income318 000
Other Income0
Revenue318 000
Cost of Goods Sold86 000
Salary Costs382 000
Depreciation0
Impairment0
Expenditure509 000
Operating Profit−191 000
Financial Income5 000
Financial Costs0
Financial Balance5 000
Dividends0
Net Income−146 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets52 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets52 000
Stock0
Total Investments0
Cash, Bank91 000
Total Current Assets1 039 000
Total Assets1 091 000
Total Equity821 000
Short-Term Group Debt0
Total Long-Term Debt202 000
Creditors0
Unpaid Taxes27 000
Dividends0
Other Current Debt41 000
Total Current Debt68 000
Total Equity and Debt1 091 000
Financial indicators2022
Return on Equity−17,78 %
Debt-to-Equity Ratio0,25
Operating Profit Margin−60,06 %
Current Ratio15,28
Quick Ratio15,28
Equity Ratio0,75
Gross Profit Margin72,96 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English